A delegation led by Europe's "Father of Stem Cells" visits our Institute's Cryomedicine CenterA delegation led by Europe's "Father of Stem Cells" visits our Institute's Cryomedicine Center
Release time:
2024-11-06
On the afternoon of November 5th, Jürgen Hescheler, known as Europe's "Father of Stem Cells," lifelong national scientific advisor for Germany, founding chairperson of the German Stem Cell Research Association, and director of the Institute of Neurophysiology at the University of Cologne, visited the Yinfeng Biotechnology Park along with Claus Wolff-Menzler, Deputy Clinical Director of the Department of Psychiatry and Psychotherapy at the University of Göttingen Medical Center and head of the Future of Medicine at the University of Göttingen, Ulf Oesinghaus, Deputy Director of Pharmacy at the University of Göttingen, Director of Lab Strategic Procurement, and Business Director of Medical Center's Analytical Laboratory Diagnostics, Jan Wende, founder of Mediq Innovation GmbH, Daniel Matthieu, founder of SmartSleep GmbH, Florian Boden, General Manager of SinoBridge Solutions' International Affairs Department, and Ye Xinjie, the China Representative of the Hannover City Trade Promotion Bureau, Germany. The delegation conducted a detailed visit to the Cryomedicine Center exhibition hall of Shandong Yinfeng Life Science Research Institute.
During the visit and exchange, Professor Jürgen Hescheler and his delegation showed great interest in Yinfeng's Life Continuation Project (focused on the cryopreservation and rewarming of tissues and organs, as well as human cryopreservation and rewarming technology) undertaken by the Yinfeng cryomedicine team. They engaged in in-depth exchanges and discussions about key technologies.
As a distinguished emblem of technological innovation in Shandong, Yinfeng's Life Continuation Project will continue to build a bridge for domestic and international government research and academic exchange, continually strengthen scientific collaborations and result transformations with global research institutions, consistently contribute to the development of cryobiomedicine, and inject continuous hope into the shared ideal of extending human life.
Latest developments
The debut and discourse of the YinFeng Life Continuation Project not only served as an authoritative demonstration of its own ethical governance framework but also contributed practical wisdom toward establishing industry norms.
Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross
Looking ahead, Yinfeng Foundation will use this recognition as an opportunity to further deepen its strategic collaboration with the Jinan Red Cross, expand cooperation in areas such as life health and emergency response, and continue to empower efforts to accelerate the construction of a "new, strong, excellent, rich, beautiful, and high-quality" modern socialist strong capital city, contributing even more Yinfeng strength to this endeavor.
The team successfully developed the CryoSIM platform, an intelligent microfluidics and deep learning-integrated system. This platform deeply integrates core technologies of deep learning and microfluidics to enable high-throughput, high-precision automated analysis of oocyte membrane permeability. It provides a novel technological tool for optimizing and advancing the clinical translation of oocyte cryopreservation techniques. Additionally, it offers an innovative practical paradigm for the application of artificial intelligence in low-temperature biomedicine and reproductive medicine.
Public Welfare Partnership: A Special Letter from the Jinan Red Cross
On the afternoon of January 30, 2026, the Jinan Red Cross presented a letter of special significance to the Shandong Yinfeng Life Science Public Welfare Foundation (hereinafter referred to as the Yinfeng Foundation).
World’s First Achievement Highlights Brand Leadership
In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.
Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference
Currently, the ovarian tissue dual activation technology has been successfully applied in clinical practice at Beijing University of Chinese Medicine Shenzhen (Longgang) Hospital, having treated over 400 patients with a treatment success rate of 70%. Over the next three years, Shandong Yinfeng Life Science Research Institute plans to use Jinan as a center to gradually expand the transformation and application of this technological achievement nationwide.
Yinfeng Life Continuation Plan
Address: Yinfeng Biotechnology Park, 1758 Gangyuan 6th Road, High-tech Zone, Jinan City, Shandong Province
Zip Code: 250102
Telephone: 0086-0531-88897351
Mobile: 0086-19953155515
Mobile website
Official WeChat Public Number
Links:Red Cross Society of China丨Shandong Red Cross Society丨Shandong Provincial Health Commission | Yinfeng Group| Yinfeng Biological Group
All rights reserved©Yinfeng Life Continuation Powered by www.300.cn SEO
